CVE-2026-9614: CWE-284: Improper Access Control in Ivanti Neurons for ITSM (On-Premises)
CVE-2026-9614 is an improper access control vulnerability in Ivanti Neurons for ITSM (On-Premises) that allows a remote authenticated attacker to gain administrative access. The vulnerability affects both cloud and on-premises versions, but this report focuses on the on-premises product. It has a high severity with a CVSS score of 8.8, indicating significant impact on confidentiality, integrity, and availability. No patch or official remediation guidance has been provided yet. There are no known exploits in the wild at this time.
AI Analysis
Technical Summary
This vulnerability (CVE-2026-9614) in Ivanti Neurons for ITSM (On-Premises) involves improper access control (CWE-284) that enables a remote attacker with valid authentication to escalate privileges and obtain administrative access. The CVSS 3.1 score of 8.8 reflects that the attack vector is network-based, requires low attack complexity, low privileges, no user interaction, and results in high impact on confidentiality, integrity, and availability. The vendor has published the vulnerability but has not yet provided a patch or official remediation level. The vulnerability is currently not known to be exploited in the wild.
Potential Impact
Successful exploitation allows a remote authenticated attacker to gain administrative privileges on the affected Ivanti Neurons for ITSM (On-Premises) system. This can lead to full system compromise, including unauthorized access to sensitive data, modification or deletion of information, and disruption of service availability. Given the administrative access gained, the impact is high across confidentiality, integrity, and availability.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until an official fix is released, organizations should carefully control and monitor authenticated user access to Ivanti Neurons for ITSM (On-Premises) and apply the principle of least privilege. Review and restrict user permissions to minimize risk of privilege escalation. Monitor for suspicious activity from authenticated users. Do not assume the vulnerability is mitigated without vendor confirmation.
CVE-2026-9614: CWE-284: Improper Access Control in Ivanti Neurons for ITSM (On-Premises)
Description
CVE-2026-9614 is an improper access control vulnerability in Ivanti Neurons for ITSM (On-Premises) that allows a remote authenticated attacker to gain administrative access. The vulnerability affects both cloud and on-premises versions, but this report focuses on the on-premises product. It has a high severity with a CVSS score of 8.8, indicating significant impact on confidentiality, integrity, and availability. No patch or official remediation guidance has been provided yet. There are no known exploits in the wild at this time.
CVSS v3.1
Score 8.8high
Weaknesses
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability (CVE-2026-9614) in Ivanti Neurons for ITSM (On-Premises) involves improper access control (CWE-284) that enables a remote attacker with valid authentication to escalate privileges and obtain administrative access. The CVSS 3.1 score of 8.8 reflects that the attack vector is network-based, requires low attack complexity, low privileges, no user interaction, and results in high impact on confidentiality, integrity, and availability. The vendor has published the vulnerability but has not yet provided a patch or official remediation level. The vulnerability is currently not known to be exploited in the wild.
Potential Impact
Successful exploitation allows a remote authenticated attacker to gain administrative privileges on the affected Ivanti Neurons for ITSM (On-Premises) system. This can lead to full system compromise, including unauthorized access to sensitive data, modification or deletion of information, and disruption of service availability. Given the administrative access gained, the impact is high across confidentiality, integrity, and availability.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until an official fix is released, organizations should carefully control and monitor authenticated user access to Ivanti Neurons for ITSM (On-Premises) and apply the principle of least privilege. Review and restrict user permissions to minimize risk of privilege escalation. Monitor for suspicious activity from authenticated users. Do not assume the vulnerability is mitigated without vendor confirmation.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- ivanti
- Date Reserved
- 2026-05-26T16:30:29.761Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
Threat ID: 6a1de30be29bf47b503a578c
Added to database: 06/01/2026, 19:52:43 UTC
Last enriched: 06/08/2026, 20:57:52 UTC
Last updated: 07/31/2026, 19:23:00 UTC
Views: 83
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
External Links
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.